Hepatitis B immunoglobulin immunoprophyl
✍
Ed Gane
📂
Article
📅
2010
🏛
John Wiley and Sons
🌐
English
⚖ 80 KB
## Key Points 1. Transplantation for HBV-related HCC is increasing in the West, whilst HBV-relate liver failure is decreasing. 2. Combination lamivudine plus HBIG reduces the risk of HBV recurrence to less than 5%. 3. Low-dose IM HBIG ihas similar efficacy and better cost effectiveness than high-d